Seil Sohn1, Jinhee Kim1, Chun Kee Chung1, Na-Rye Lee1, Eunjung Park1, Ung-Kyu Chang1, Moon Jun Sohn1, Sung Hwan Kim1. 1. Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea (S.S., C.K.C.); Neuroscience Research Institute, Seoul National University Medical Research Center, Seoul, Korea (S.S., C.K.C.); Clinical Research Institute, Seoul National University Hospital, Seoul, Korea (S.S., C.K.C.); Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Korea (C.K.C.); Department of Nursing, College of Medicine, Chosun University, Gwangju, Korea (J.K.); National Evidence-based Healthcare Collaborating Agency, Seoul, Korea (N.-R.L., E.P.); Department of Neurosurgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Science, Seoul, Korea (U.-K.C.); Department of Neurosurgery, Ilsan Paik Hospital, College of Medicine, Inje University, Gimhae, Korea (M.J.S.); Department of Radiation Oncology, St. Vincent's Hospital, School of Medicine, The Catholic University of Korea, Suwon, Korea (S.H.K.).
Abstract
BACKGROUND: The aim of this nationwide study was to describe the incidence and health care utilization of adult Korean patients with primary malignant, primary nonmalignant, and metastatic spine tumors between 2009 and 2012. METHODS: Patients with primary and metastatic spine tumors were identified from the Korean Health Insurance Review and Assessment Service database between January 1, 2009, and December 31, 2012. Demographics, incidence rate, annual medical cost, and annual hospital stay of each new patient were reviewed. RESULTS: Of 1600 primary spine tumors diagnosed from 2009 to 2012, 373 (23.3%) were malignant, and 1227 (76.7%) were nonmalignant. The most common tumor type was neoplasm of spinal cord among primary malignant (C72.0, 51.5%) and primary nonmalignant (D33.4, 66.2%) spine tumors. Differences in primary malignant, primary nonmalignant, and metastatic spine tumor incidence by sex were significant (P = .004, <.001, and <.001, respectively). The annual incidence rate of primary nonmalignant and metastatic spine tumors increased significantly over the study period (P = .005 and <.001, respectively). Lung, liver/biliary, and breast were the most prevalent original tumor sites for metastatic spine tumors. In 2011, average annual medical costs associated with treatment of primary malignant, primary nonmalignant, and metastatic tumors were US $15 223, $6502, and $16 038, respectively. Average annual hospital stay durations for primary malignant, primary nonmalignant, and metastatic spine tumors in 2011 were 103.4, 61.7, and 79.6 days, respectively. CONCLUSIONS: This is the first nationwide analysis of spine tumors, including metastatic spine tumors, in Asia.
BACKGROUND: The aim of this nationwide study was to describe the incidence and health care utilization of adult Korean patients with primary malignant, primary nonmalignant, and metastatic spine tumors between 2009 and 2012. METHODS: Patients with primary and metastatic spine tumors were identified from the Korean Health Insurance Review and Assessment Service database between January 1, 2009, and December 31, 2012. Demographics, incidence rate, annual medical cost, and annual hospital stay of each new patient were reviewed. RESULTS: Of 1600 primary spine tumors diagnosed from 2009 to 2012, 373 (23.3%) were malignant, and 1227 (76.7%) were nonmalignant. The most common tumor type was neoplasm of spinal cord among primary malignant (C72.0, 51.5%) and primary nonmalignant (D33.4, 66.2%) spine tumors. Differences in primary malignant, primary nonmalignant, and metastatic spine tumor incidence by sex were significant (P = .004, <.001, and <.001, respectively). The annual incidence rate of primary nonmalignant and metastatic spine tumors increased significantly over the study period (P = .005 and <.001, respectively). Lung, liver/biliary, and breast were the most prevalent original tumor sites for metastatic spine tumors. In 2011, average annual medical costs associated with treatment of primary malignant, primary nonmalignant, and metastatic tumors were US $15 223, $6502, and $16 038, respectively. Average annual hospital stay durations for primary malignant, primary nonmalignant, and metastatic spine tumors in 2011 were 103.4, 61.7, and 79.6 days, respectively. CONCLUSIONS: This is the first nationwide analysis of spine tumors, including metastatic spine tumors, in Asia.
Authors: Brook I Martin; Sohail K Mirza; Bryan A Comstock; Darryl T Gray; William Kreuter; Richard A Deyo Journal: Spine (Phila Pa 1976) Date: 2007-02-01 Impact factor: 3.468
Authors: O Zaikova; K-E Giercksky; S D Fosså; S Kvaløy; T B Johannesen; S Skjeldal Journal: Clin Oncol (R Coll Radiol) Date: 2009-10-21 Impact factor: 4.126
Authors: Seung-Ji Lim; Han-Joong Kim; Chung-Mo Nam; Hoo-Sun Chang; Young Hwa Jang; Sera Kim; Hye Young Kang Journal: J Prev Med Public Health Date: 2009-07
Authors: Ruben Van den Brande; Erwin Mj Cornips; Marc Peeters; Piet Ost; Charlotte Billiet; Erik Van de Kelft Journal: J Bone Oncol Date: 2022-07-09 Impact factor: 4.491